Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytodyn Inc. (CYDY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytodyn Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1175680.
Total stock buying since 2014: $1,140,569.
Total stock sales since 2014: $30,054,426.
Total stock option exercises since 2014: $12,913,590.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 0 | $0 | 1,454,888 | $962,277 |
| 2020 | 573,500 | $961,864 | 7,841,774 | $30,054,426 | 12,509,356 | $7,318,469 |
| 2019 | 0 | $0 | 0 | $0 | 7,751,281 | $2,899,512 |
| 2016 | 26,000 | $17,168 | 0 | $0 | 0 | $0 |
| 2015 | 281,686 | $140,842 | 0 | $0 | 0 | $0 |
| 2014 | 28,500 | $20,695 | 0 | $0 | 2,666,666 | $1,733,332 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-09 | 0 | $0 | 0 | $0 | 1,288,888 | $837,777 |
| 2021-02 | 0 | $0 | 0 | $0 | 166,000 | $124,500 |
| 2020-12 | 0 | $0 | 1,820,600 | $10,383,003 | 1,820,600 | $1,446,347 |
| 2020-11 | 193,500 | $497,294 | 0 | $0 | 0 | $0 |
| 2020-10 | 130,000 | $323,320 | 0 | $0 | 0 | $0 |
| 2020-05 | 250,000 | $141,250 | 3,801,337 | $11,833,179 | 1,228,815 | $615,928 |
| 2020-04 | 0 | $0 | 2,219,837 | $7,838,244 | 7,640,269 | $4,928,654 |
| 2020-02 | 0 | $0 | 0 | $0 | 1,819,672 | $327,540 |
| 2019-07 | 0 | $0 | 0 | $0 | 1,000,000 | $300,000 |
| 2019-06 | 0 | $0 | 0 | $0 | 1,475,000 | $561,500 |
| 2019-05 | 0 | $0 | 0 | $0 | 5,276,281 | $2,038,012 |
| 2016-10 | 26,000 | $17,168 | 0 | $0 | 0 | $0 |
| 2015-06 | 73,380 | $36,690 | 0 | $0 | 0 | $0 |
| 2015-05 | 208,306 | $104,152 | 0 | $0 | 0 | $0 |
| 2014-11 | 0 | $0 | 0 | $0 | 2,666,666 | $1,733,332 |
| 2014-10 | 28,500 | $20,695 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-23 | Naydenov Jordan G (Director) | Option Ex | 1,288,888 | .65 | 837,777 |
| 2021-02-05 | Kelly Scott A. (Chairman & CMO) | Option Ex | 166,000 | .75 | 124,500 |
| 2020-12-22 | Mulholland Michael D. (Chief Financial Officer) | Sale | 711,801 | 6.37 | 4,533,460 |
| 2020-12-22 | Mulholland Michael D. (Chief Financial Officer) | Option Ex | 711,801 | 1.06 | 758,068 |
| 2020-12-21 | Mulholland Michael D. (Chief Financial Officer) | Sale | 589,797 | 5.58 | 3,292,246 |
| 2020-12-21 | Mulholland Michael D. (Chief Financial Officer) | Option Ex | 589,797 | .75 | 440,578 |
| 2020-12-18 | Mulholland Michael D. (Chief Financial Officer) | Sale | 487,002 | 4.95 | 2,411,633 |
| 2020-12-18 | Mulholland Michael D. (Chief Financial Officer) | Option Ex | 487,002 | .48 | 235,221 |
| 2020-12-17 | Mulholland Michael D. (Chief Financial Officer) | Sale | 32,000 | 4.55 | 145,664 |
| 2020-12-17 | Mulholland Michael D. (Chief Financial Officer) | Option Ex | 32,000 | .39 | 12,480 |
| 2020-11-02 | Naydenov Jordan G (Director) | Buy | 193,500 | 2.57 | 497,294 |
| 2020-10-23 | Colachis Arian (GC and Corporate Secretary) | Buy | 10,000 | 2.50 | 25,000 |
| 2020-10-23 | Naydenov Jordan G (Director) | Buy | 120,000 | 2.49 | 298,320 |
| 2020-05-04 | Kelly Scott A. (Chief Medical Officer) | Option Ex | 8,334 | .52 | 4,333 |
| 2020-05-04 | Pourhassan Nader (President & CEO) | Sale | 1,201,652 | 2.79 | 3,352,609 |
| 2020-05-04 | Pourhassan Nader (President & CEO) | Option Ex | 30,933 | .39 | 12,063 |
| 2020-05-01 | Kelly Scott A. (Chief Medical Officer) | Buy | 250,000 | .56 | 141,250 |
| 2020-05-01 | Kelly Scott A. (Chief Medical Officer) | Sale | 1,200,000 | 3.26 | 3,911,999 |
| 2020-05-01 | Kelly Scott A. (Chief Medical Officer) | Option Ex | 1,189,548 | .50 | 599,532 |
| 2020-05-01 | Pourhassan Nader (President & CEO) | Sale | 1,399,685 | 3.26 | 4,568,571 |
| 2020-04-30 | Pourhassan Nader (President & CEO) | Sale | 2,219,837 | 3.53 | 7,838,244 |
| 2020-04-30 | Pourhassan Nader (President & CEO) | Option Ex | 5,381,167 | .71 | 3,799,103 |
| 2020-04-01 | Welch David F (Director) | Option Ex | 2,259,102 | .50 | 1,129,551 |
| 2020-02-21 | Welch David F (Director) | Option Ex | 1,819,672 | .18 | 327,540 |
| 2019-07-31 | Welch David F (Director) | Option Ex | 1,000,000 | .30 | 300,000 |
| 2019-06-12 | Kelly Scott A. (Director) | Option Ex | 50,000 | .40 | 20,000 |
| 2019-06-12 | Dockery Carl (Director) | Option Ex | 1,425,000 | .38 | 541,500 |
| 2019-05-08 | Klump Michael A (Director) | Option Ex | 3,625,000 | .38 | 1,377,500 |
| 2019-05-08 | Welch David F (Director) | Option Ex | 1,651,281 | .40 | 660,512 |
| 2016-10-21 | Pourhassan Nader (President and CEO) | Buy | 15,000 | .66 | 9,930 |
| 2016-10-17 | Mulholland Michael D. (CFO, Treasurer and Secretary) | Buy | 11,000 | .66 | 7,238 |
| 2015-06-05 | Dockery Carl (Director) | Buy | 36,690 | .50 | 18,345 |
| 2015-06-05 | Alpha Venture Capital Partners, L.p. (10% Owner) | Buy | 36,690 | .50 | 18,345 |
| 2015-05-05 | Dockery Carl (Director) | Buy | 104,153 | .50 | 52,076 |
| 2015-05-05 | Alpha Venture Capital Partners, L.p. (10% Owner) | Buy | 104,153 | .50 | 52,076 |
| 2014-11-14 | Naydenov Jordan G (Director) | Option Ex | 2,666,666 | .65 | 1,733,332 |
| 2014-10-30 | Caracciolo Anthony (Director) | Buy | 26,000 | .72 | 18,720 |
| 2014-10-15 | Mulholland Michael D. (CFO, Treasurer and Secretary) | Buy | 2,500 | .79 | 1,975 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYDY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytodyn Inc. (symbol CYDY, CIK number 1175680) see the Securities and Exchange Commission (SEC) website.